Literature DB >> 14462727

[The effect of Persantin on heart muscle sarcosomes].

G LAUDAHN.   

Abstract

Entities:  

Keywords:  HEART/pharmacology; VASODILATOR AGENTS/pharmacology

Mesh:

Substances:

Year:  1961        PMID: 14462727     DOI: 10.1007/BF02157978

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


× No keyword cloud information.
  9 in total

1.  [Clinical and experimental studies on persantin in coronary diseases].

Authors:  S GREIF
Journal:  Wien Med Wochenschr       Date:  1960-06-04

2.  [Studies on the effect of 2, 6-bis(diethanolamino)-4, 8-dipiperidino-pyrimido[5, 4-d]-pyrimidine on the heart and circulation].

Authors:  T HOCKERTS; G BOGELMANN
Journal:  Arzneimittelforschung       Date:  1959-01

3.  [The effect of isolated liver cell mitochondria on acute injuries of the rat liver caused by carbon tetrachloride. 3. The significance of preserved phosphorylation ability of the applied mitochondria suspensions].

Authors:  G LAUDAHN; C J LUEDERS
Journal:  Arzneimittelforschung       Date:  1960-12

4.  [On the therapy of coronary insufficiency].

Authors:  L DUETSCH
Journal:  Ther Ggw       Date:  1960-05

5.  [The behavior of lactic and pyruvic acids, SGOT and SGPT under persantin treatment].

Authors:  E ALBACH
Journal:  Med Welt       Date:  1960-04-30

6.  [Clinical experiences and experimental studies on a new pyrimido-pyrimidine derivative].

Authors:  H W KNIPPING; W BOLT; K MIKULICZ
Journal:  Arzneimittelforschung       Date:  1960-05

7.  [Electron microscopic examination of liver parenchyma in acute hypoxia].

Authors:  E MOLBERT; D GUERRITORE
Journal:  Beitr Pathol Anat       Date:  1957

8.  [The pathogenetic significance of oxidation inhibition].

Authors:  F BUCHNER
Journal:  Schweiz Med Wochenschr       Date:  1958-01-25

9.  [Electron microscopic picture of the liver parenchyma cell after histological hypoxydosis].

Authors:  E MOLBERT
Journal:  Beitr Pathol Anat       Date:  1957
  9 in total
  11 in total

Review 1.  [EFFECT OF DRUGS ON THE ENERGY-RELEASING REACTIONS OF METABOLISM].

Authors:  D NEUBERT
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1963-08-22

2.  SOME FACTORS INFLUENCING THE RECOVERY OF ISOLATED MYOCARDIUM FROM ACUTE ANOXIA.

Authors:  R G PENN
Journal:  Br J Pharmacol Chemother       Date:  1965-02

3.  Inhibition of adrenergic cardiopathies by drugs. II. Anticoagulants.

Authors:  F W Eichbaum; S Zyngier
Journal:  Arch Kreislaufforsch       Date:  1970 May-Jun

4.  Influence of the agonal period on the postmortem metabolic state of the heart. A problem in cardiac preservation.

Authors:  P Lundsgaard-Hansen; W Schilt; L Heitmann; M Oroz; A Büchler; A Lemeunier
Journal:  Ann Surg       Date:  1971-11       Impact factor: 12.969

5.  Controlled trial of dipyridamole in cerebral vascular disease.

Authors:  J Acheson; G Danta; E C Hutchinson
Journal:  Br Med J       Date:  1969-03-08

Review 6.  [Comparative animal experiment studies of the prolongation of the revival time of the heart and the whole organ in normothermia by pharmacological pretreatment].

Authors:  H R Schoen
Journal:  Arch Kreislaufforsch       Date:  1968-10

7.  [On the effect of overdosage of persantin and low atmospheric pressure on myocardial ultrastructures in the rat].

Authors:  R Poche; T U Hausamen
Journal:  Virchows Arch Pathol Anat Physiol Klin Med       Date:  1965-06-01

8.  Inhibition of adrenergic cardiopathies by drugs. I. Dipyridamole.

Authors:  F W Eichbaum; S Zyngier; E P De Campos
Journal:  Arch Kreislaufforsch       Date:  1970 May-Jun

9.  Cardiac histological and serum-biochemical changes produced by various adrenergic stimulant drugs in the rat.

Authors:  E Marmo; A P Caputi; R K Saini
Journal:  Basic Res Cardiol       Date:  1973 May-Jun       Impact factor: 17.165

10.  [The effect of 2,6-bis (diethanolamino)-4,8-dipiperidino-pyrimido-(5,4-d)-pyrimidine (Persantin) on the respiration of mitochondria in low O2 pressure].

Authors:  M FRIMMER; D HEGNER; W WINKELMANN
Journal:  Klin Wochenschr       Date:  1963-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.